Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Turner Syndrome clinical trials
8 of 15 indexed Turner Syndrome trials are currently recruiting.
15 US clinical trials · 8 currently recruiting
Turner Syndrome is the subject of 15 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is University of Colorado, Denver, running 2 of these trials.
The research picture
Turner Syndrome has 15 registered US clinical trials, 8 of them open to new participants right now, about 53% of the total.
- 8
- recruiting participants now
- 53%
- of trials open to enrollment
- 4
- in Phase 3–4 (later-stage)
- 2
- top sponsor: University of Colorado, Denver
Active & Recent Trials
15 total, page 1 of 1
Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry
University of Colorado, Denver
NCT05052606
Natural History of Noncirrhotic Portal Hypertension
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT02417740
UTHealth Turner Syndrome Research Registry
The University of Texas Health Science Center, Houston
NCT03185702
Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NCT04948658
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Ascendis Pharma A/S
NCT07221851
A Basket Study of Vosoritide in Children With Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment
BioMarin Pharmaceutical
NCT06668805
Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome
Children's Mercy Hospital Kansas City
NCT06834594
Vosoritide for Short Stature in Turner Syndrome
Roopa Kanakatti Shankar, MBBS, MS
NCT05849389
A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome
Ascendis Pharma Endocrinology Division A/S
NCT05690386
A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9
Novo Nordisk A/S
NCT05723835
Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
Progenity
NCT02787486
Risk of Diabetes in Young Turner Syndrome Patients
Children's Hospital Medical Center, Cincinnati
NCT02160717
The Effect of Growth Hormone in Very Young Girls With Turner Syndrome
Eli Lilly and Company
NCT00406926
Dry Eye in Women With Turner Syndrome and Women With Premature Ovarian Failure
National Eye Institute (NEI)
NCT00471731
Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
University of Colorado, Denver
NCT02213484
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 3 |
| Phase 4 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Turner Syndrome Trial Landscape
15 indexed Turner Syndrome studies · 8 recruiting (53%).
Phase mix: 4 late (III/IV) vs 3 early (I/II).
Top sponsor: University of Colorado, Denver (2 trials), 9 others listed. 15 shown below, recruiting first.
How to read this condition's trial landscape
That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation, eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Turner Syndrome?
PlainTrial tracks 15 US clinical trials for Turner Syndrome, of which 8 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Turner Syndrome?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.